Prevention and Management of Peptide Receptor Radionuclide Therapy-Induced Hypertensive Crisis in a Patient With Metastatic Pheochromocytoma

By afschroeder • April 7, 2026

Yu R, Gardner L, Salavati A, Bahri S. Prevention and Management of Peptide Receptor Radionuclide Therapy-Induced Hypertensive Crisis in a Patient With Metastatic Pheochromocytoma. AACE Endocrinol Diabetes. 2025 Nov 13;13(2):303-307. doi: 10.1016/j.aed.2025.11.001. PMID: 41938296; PMCID: PMC13043445.

Tags: Endocrinology, hypertensive crisis, lutetium-177 DOTATATE, metastatic pheochromocytoma, metyrosine, peptide receptor radionuclide therapy, Publications

Counseling Female Thyroid Cancer Patients on Radioactive Iodine and Fertility

Leung AM, Brent GA, Larson SM, Osborne JR, Flavell RR, Ringel MD, Sosa JA. Counseling Female Thyroid Cancer Patients on Radioactive Iodine and Fertility. Thyroid.[...]

The ULK1-NCOA3 axis restrains de novo lipogenesis and prevents diet-induced steatohepatitis and fibrosis in mice

Koo YD, Castillo RT, Sukumaran Nair A, Garneau M, Gochee C, Campbell ZV, Vakil TS, Ha J, Marti A, Soto J, Das D, Martinez-Lopez N,[...]

Omitting Radioactive Iodine after Therapeutic Lateral Neck Dissection May Be the Next Step in De-Escalating Initial Treatment of Papillary Thyroid Cancer

Yeh MW. Omitting Radioactive Iodine after Therapeutic Lateral Neck Dissection May Be the Next Step in De-Escalating Initial Treatment of Papillary Thyroid Cancer. Thyroid. 2026[...]